NATURAL GROCERS BY VITAMIN C (NGVC) Stock Analyst Earnings Estimates
NYSE:NGVC - New York Stock Exchange, Inc. - US63888U1088 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 1.09B 3.23% | 1.141B 4.68% | 1.242B 8.86% | 1.258B 1.32% | |
| EBITDA YoY % growth | 61.21M 3.00% | 62.521M 2.14% | 80.679M 29.04% | 63.629M -21.13% | |
| EBIT YoY % growth | 33.3M 11.74% | 33.615M 0.95% | 49.749M 48.00% | 28.343M -43.03% | |
| Operating Margin | 3.06% | 2.95% | 4.01% | 2.25% | |
| EPS YoY % growth | 0.93 2.20% | 1.02 9.68% | 1.48 45.10% | 0.87 -41.42% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 0.39 50.00% | 0.19 | 0.20 | 101.24% |
| Q3 2024 Q2Q % growth | 0.40 29.03% | 0.30 | 0.10 | 35.23% |
| Q2 2024 Q2Q % growth | 0.35 34.62% | 0.30 | 0.05 | 18.32% |
| Q1 2024 Q2Q % growth | 0.34 78.95% | 0.19 | 0.15 | 75.44% |
| Q4 2023 Q2Q % growth | 0.26 188.89% | 0.20 | 0.06 | 27.45% |
| Q3 2023 Q2Q % growth | 0.31 82.35% | 0.15 | 0.16 | 102.61% |
| Q2 2023 Q2Q % growth | 0.26 -7.14% | 0.20 | 0.06 | 27.45% |
| Q1 2023 Q2Q % growth | 0.19 -51.28% | 0.32 | -0.13 | -39.91% |
| Q4 2022 Q2Q % growth | 0.09 -71.88% | 0.15 | -0.06 | -41.18% |
| Q3 2022 Q2Q % growth | 0.17 -22.73% | 0.20 | -0.03 | -16.67% |
| Q2 2022 Q2Q % growth | 0.28 33.33% | 0.18 | 0.10 | 52.51% |
| Q1 2022 Q2Q % growth | 0.39 143.75% | % | ||
| Q4 2021 Q2Q % growth | 0.32 100.00% | % | ||
| Q3 2021 Q2Q % growth | 0.22 4.76% | % | ||
| Q2 2021 Q2Q % growth | 0.21 -51.16% | % | ||
| Q1 2021 Q2Q % growth | 0.16 100.00% | % | ||
| Q4 2020 Q2Q % growth | 0.16 166.67% | % | ||
| Q3 2020 Q2Q % growth | 0.21 133.33% | % | ||
| Q2 2020 Q2Q % growth | 0.43 152.94% | 0.09 | 0.34 | 368.41% |
| Q1 2020 Q2Q % growth | 0.08 -20.00% | 0.09 | -0.01 | -7.73% |
| Q4 2019 Q2Q % growth | 0.06 | 0.06 | 0.00 | 3.20% |
| Q3 2019 Q2Q % growth | 0.09 | 0.07 | 0.02 | 25.16% |
| Q2 2019 Q2Q % growth | 0.17 | 0.16 | 0.01 | 7.30% |
| Q1 2019 Q2Q % growth | 0.10 | 0.05 | 0.05 | 119.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 322.66M 9.35% | % | ||
| Q3 2024 Q2Q % growth | 309.08M 9.68% | % | ||
| Q2 2024 Q2Q % growth | 308.09M 8.77% | % | ||
| Q1 2024 Q2Q % growth | 301.75M 7.58% | % | ||
| Q4 2023 Q2Q % growth | 295.075M 7.61% | 290.7M | 4.375M | 1.50% |
| Q3 2023 Q2Q % growth | 281.791M 5.82% | 277.44M | 4.351M | 1.57% |
| Q2 2023 Q2Q % growth | 283.245M 4.21% | 279.48M | 3.765M | 1.35% |
| Q1 2023 Q2Q % growth | 280.5M 1.15% | 280.5M | 0.00% | |
| Q4 2022 Q2Q % growth | 274.2M 0.59% | 287.64M | -13.44M | -4.67% |
| Q3 2022 Q2Q % growth | 266.3M 2.98% | % | ||
| Q2 2022 Q2Q % growth | 271.8M 4.86% | % | ||
| Q1 2022 Q2Q % growth | 277.3M 4.64% | % | ||
| Q4 2021 Q2Q % growth | 272.6M 3.18% | % | ||
| Q3 2021 Q2Q % growth | 258.6M -2.45% | % | ||
| Q2 2021 Q2Q % growth | 259.2M -6.59% | % | ||
| Q1 2021 Q2Q % growth | 265M 15.22% | % | ||
| Q4 2020 Q2Q % growth | 264.2M 16.29% | % | ||
| Q3 2020 Q2Q % growth | 265.1M 18.14% | % | ||
| Q2 2020 Q2Q % growth | 277.5M 20.44% | 251.618M | 25.882M | 10.29% |
| Q1 2020 Q2Q % growth | 230M 3.84% | 252.836M | -22.836M | -9.03% |
| Q3 2019 Q2Q % growth | 224.4M | 230.78M | -6.38M | -2.76% |
| Q2 2019 Q2Q % growth | 230.4M | 234.38M | -3.98M | -1.70% |
| Q1 2019 Q2Q % growth | 221.5M | 222.75M | -1.25M | -0.56% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |